Sex differences in the hypertensive population with chronic ischemic heart disease

Vivencio Barrios1, Carlos Escobar, Vicente Bertomeu

  • 1Department of Cardiology, Hospital Ramón y Cajal, Madrid, Spain. vbarriosa@meditex.es

Insights

Clinical management of chronic ischemic heart disease and hypertension shows sex differences. Men had better blood pressure and LDL-C control rates, despite women presenting with more comorbidities.

Area of Science:

  • Cardiology
  • Clinical Medicine
  • Public Health

Background:

  • Chronic ischemic heart disease and hypertension are significant clinical challenges.
  • Understanding sex differences in management is crucial for optimizing patient outcomes.
  • The CINHTIA survey provides insights into current clinical practices in Spain.

Purpose of the Study:

  • To assess the clinical management of hypertensive patients with chronic ischemic heart disease.
  • To examine sex differences in patient characteristics and treatment outcomes.
  • To evaluate blood pressure and LDL-C control rates in this patient population.

Main Methods:

  • A nationwide survey (CINHTIA) of 2024 patients with hypertension and chronic ischemic heart disease.
  • Data collection on patient demographics, comorbidities, and management strategies.
  • Analysis of sex-based differences in clinical presentation and control rates.

Main Results:

  • Women were older, with higher BMI and more atrial fibrillation; men had higher rates of dyslipidemia, smoking, and peripheral arterial disease.
  • Diabetes, left ventricular hypertrophy, and heart failure were more prevalent in women.
  • Blood pressure and LDL-C control rates were significantly better in men (44.9% vs 30.5% and 33.0% vs 25.0%, respectively).
  • Men underwent stress testing and coronary angiography more frequently.

Conclusions:

  • Significant sex disparities exist in the clinical management of hypertensive patients with chronic ischemic heart disease.
  • Despite poorer control rates, men received more diagnostic procedures.
  • Further research is needed to address these sex differences and improve care for all patients.

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Special considerations while measuring blood pressure01:28

Special considerations while measuring blood pressure

When assessing blood pressure (BP), healthcare professionals must consider various factors and potential unexpected outcomes to ensure accurate readings and provide proper patient care. Adhering to these guidelines is essential to achieving the most reliable results.
Monitoring Both Arms:
Monitoring BP in both arms during the initial assessment is advisable, as the systolic value may differ by five to ten mm Hg between arms. For subsequent BP assessments, use the arm with the higher reading.
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...